» Articles » PMID: 15234326

Inhibition of SARS-coronavirus Infection in Vitro by S-nitroso-N-acetylpenicillamine, a Nitric Oxide Donor Compound

Overview
Publisher Elsevier
Date 2004 Jul 6
PMID 15234326
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The recent outbreak of severe acute respiratory syndrome (SARS) warrants the search for effective antiviral agents to treat the disease. This study describes the assessment of the antiviral potential of nitric oxide (NO) against SARS coronavirus (SARS-CoV) strain Frankfurt-1 replicating in African Green Monkey (Vero E6) cells.

Results: Two organic NO donor compounds, S-nitroso-N-acetylpenicillamine (SNAP) and sodium nitroprusside (SNP), were tested in a broad range of concentrations. The non-nitrosylated form of SNAP, N-acetylpenicillamine (NAP), was included as a control compound in the assay. Antiviral activity was estimated by the inhibition of the SARS-CoV cytopathic effect in Vero E6 cells, determined by a tetrazolium-based colorimetric method. Cytotoxicity of the compounds was tested in parallel.

Conclusion: The survival rate of SARS-CoV infected cells was greatly increased by the treatment with SNAP, and the concentration of this compound needed to inhibit the viral cytopathic effect to 50% was 222 microM, with a selectivity index of 3. No anti-SARS-CoV effect could be detected for SNP and NAP.

Citing Articles

Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective.

Sanduzzi Zamparelli S, Sanduzzi Zamparelli A, Bocchino M Life (Basel). 2025; 15(1).

PMID: 39860053 PMC: 11766556. DOI: 10.3390/life15010113.


Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition.

Sanchez-Garcia S, Castrillo A, Bosca L, Prieto P Antioxidants (Basel). 2024; 13(11).

PMID: 39594443 PMC: 11591382. DOI: 10.3390/antiox13111301.


Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms.

Garren M, Ashcraft M, Qian Y, Douglass M, Brisbois E, Handa H Appl Mater Today. 2024; 22:100887.

PMID: 38620577 PMC: 7718584. DOI: 10.1016/j.apmt.2020.100887.


The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.

Xiao S, Yuan Z, Huang Y Int J Mol Sci. 2023; 24(24).

PMID: 38138990 PMC: 10742813. DOI: 10.3390/ijms242417162.


High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.

Di Fenza R, Shetty N, Gianni S, Parcha V, Giammatteo V, Safaee Fakhr B Am J Respir Crit Care Med. 2023; 208(12):1293-1304.

PMID: 37774011 PMC: 10765403. DOI: 10.1164/rccm.202304-0637OC.


References
1.
Bates J, Baker M, Guerra Jr R, Harrison D . Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol. 1991; 42 Suppl:S157-65. DOI: 10.1016/0006-2952(91)90406-u. View

2.
Marks G, Mclaughlin B, Brown L, Beaton D, Booth B, Nakatsu K . Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 x g supernatant: biotransformation and nitric oxide formation. Can J Physiol Pharmacol. 1991; 69(6):889-92. DOI: 10.1139/y91-135. View

3.
Kowaluk E, Seth P, Fung H . Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther. 1992; 262(3):916-22. View

4.
Jeong H, Kim J . Induction of inducible nitric oxide synthase expression by 18beta-glycyrrhetinic acid in macrophages. FEBS Lett. 2002; 513(2-3):208-12. DOI: 10.1016/s0014-5793(02)02311-6. View

5.
Goodwin C, Holt S, Downes S, Marshall N . Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods. 1995; 179(1):95-103. DOI: 10.1016/0022-1759(94)00277-4. View